Yugang Fu
Overview
Explore the profile of Yugang Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Fu Y, Wang Y, Zheng Y, Zhang K, Li Y
Heliyon
. 2024 Jun;
10(11):e31860.
PMID: 38841509
Background: Constipation is one of the chronic gastrointestinal functional diseases that affects the quality of life. While Qi Lang Formula (QLF) has demonstrated effectiveness in alleviating constipation symptoms, its precise...
2.
Zheng Y, Zhao L, Xiong Z, Huang C, Yong Q, Fang D, et al.
Clin Mol Hepatol
. 2024 Apr;
30(3):449-467.
PMID: 38623614
Background/aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become an increasingly important health challenge, with a substantial rise linked to changing lifestyles and global obesity. Ursolic acid, a natural pentacyclic...
3.
Wang J, Li J, Fu Y, Zhu Y, Lin L, Li Y
Int J Mol Med
. 2024 Feb;
53(4).
PMID: 38362962
Phospholipids (PLs) are principle constituents of biofilms, with their fatty acyl chain composition significantly impacting the biophysical properties of membranes, thereby influencing biological processes. Recent studies have elucidated that fatty...
4.
Fu Y, Li J, Zhu Y, Chen C, Liu J, Gu S, et al.
BMC Med Genomics
. 2023 Oct;
16(1):232.
PMID: 37789337
Background: Epidemiological studies have indicated a potential link between the gut microbiome and autoimmune liver disease (AILD) such as autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis...
5.
Cheng X, Wei Y, Fu Y, Li J, Han L
Front Immunol
. 2022 Dec;
13:1052182.
PMID: 36532007
Background: Colon adenocarcinoma (COAD) is a fatal disease, and its cases are constantly increasing worldwide. Further, the therapeutic and management strategies for patients with COAD are still unsatisfactory due to...
6.
Li J, Fu Y, Zhang K, Li Y
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146640
Background: The plasma membrane provides a highly dynamic barrier for cancer cells to interact with their surrounding microenvironment. Membrane tension, a pivotal physical property of the plasma membrane, has attracted...